SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform - Concepedia

Concepedia

Publication | Open Access

SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform

DOI Full Paper Access

126

Citations

57

References

2018

Year

John M. Hatcher, Guowei Wu, Chuyue Zeng, Jie Zhu, Meng Fan, Sherrina Patel, Wen‐qiu Wang, Scott B. Ficarro, Alan L. Leggett, Chelsea E. Powell,

Cell chemical biology

Anti-angiogenic IsoformAngiogenesisCovalent Srpk1/2 InhibitorMedicinePotently Converts VegfVascular BiologyNeovascularizationVascular Endothelial Growth FactorPharmacologyCell BiologyCell SignalingTumor BiologyCancer Growth

References

	Year	Citations

Page 1

Page 1